Navigation Links
BlueFire Ethanol To Present at BIO 2009 International Convention
Date:5/12/2009

IRVINE, Calif., May 12 /PRNewswire-FirstCall/ -- BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), a company changing the world's transportation fuel paradigm through the production of ethanol from non-food cellulosic wastes, has announced that the company's President and CEO, Arnold Klann, will participate in a panel discussion titled "From Field to Wheels: What's Going to Work in Biofuels?" on Thursday, May 21 at the BIO 2009 International Convention, the largest global event for the biotechnology industry, which will be held at the Georgia World Congress Center in Atlanta.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090511/BLUEFIRELOGO)

The esteemed panelists chosen to participate in the discussion alongside BlueFire CEO Arnold Klann include Harrison Dillon, President and Chief Technology Officer at Solazyme; Kinkead Reiling, Co-Founder and Senior Vice President of Corporate Development at Amyris; Aristides Patrinos, President at Synthetic Genomics, Inc., and moderating the discussion will be Laurence Alexander, Managing Director at Jefferies & Company, Inc.

"BlueFire Ethanol is pleased to participate in this panel discussion with other prominent industry leaders to discuss the viability of the various emerging solutions to the question of what is going to work in biofuels," said Arnold Klann. "BlueFire's cellulosic conversion process provides a commercially-viable method of generating biofuels from a variety of non-food source feedstocks, thereby offering a cost-effective method to offset the import of energy and reduce petroleum consumption. In light of the recently-announced federal support for biofuels initiatives, we are optimistic that technologies such as ours will soon become commercially available and help pave the way towards energy independence."

With the goal of expanding biotech innovations that help "heal, fuel, and feed the world," BIO 2009 International Convention will deliver the partnering tools, licensing tips and other industry resources necessary to meet current economic challenges and to strengthen biotech businesses for the future.

BlueFire Ethanol is currently focused on developing its first ethanol biorefinery in Lancaster, California. The Lancaster facility will use post-sorted cellulosic wastes diverted from landfills in Southern California to produce 3.9 million gallons of fuel-grade ethanol per year. The company was also awarded $40 million from the U.S. Department of Energy for construction of a second plant in Southern California, and has received the first installment of funding from the DOE for the development of the BlueFire Mecca, LLC plant in Southern California.

BIO 2009 International Convention will take place May 18-21, 2009 at the Georgia World Congress Center in Atlanta. For more information or to attend the conference, visit http://convention.bio.org/.

About BlueFire Ethanol Fuels

BlueFire Ethanol Fuels, Inc. was established to deploy a commercially ready, patented and proven Concentrated Acid Hydrolysis Technology Process for the profitable conversion of cellulosic ("Green Waste") waste materials to ethanol, a viable alternative to gasoline. BlueFire is the only cellulose-to-ethanol company worldwide with demonstrated production of ethanol from urban trash (post-sorted MSW), rice and wheat straws, wood waste and other agricultural residues.

BlueFire is one of four ethanol companies awarded funding from the U.S. Department of Energy to construct ethanol production facilities. Unlike remote corn ethanol production plants, BlueFire's biorefineries will be located in markets with the highest demand for ethanol. This dramatically reduces delivery costs and increases biofuels supply, while providing a unique waste processing technology that helps cities better manage the problem of overflowing landfills. For more information, visit www.BlueFireEthanol.com.

Forward-Looking Statements

Statements about BlueFire Ethanol, Inc.'s expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as the term is defined in the Private Litigation Reform Act of 1995. BlueFire's actual results could differ materially from expected results. BlueFire undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Should events occur which materially affect any comments made within this press release; BlueFire will appropriately inform the public.


'/>"/>
SOURCE BlueFire Ethanol Fuels, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. President Bill Clinton to Speak at the Ethanol Summit in Brazil
2. Sugarcane Ethanol Industry Eager to Implement U.S. Renewable Fuel Standard
3. Brazils top automakers to distribute 2 million copies of the Ethanol Handbook in partnership with the Brazilian Sugarcane Industry Association
4. New Genomatica Chemical Process Targets Ailing Ethanol Assets
5. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
6. New catalyst paves the path for ethanol-powered fuel cells
7. Panda Ethanols Hereford, Texas Subsidiary Files Voluntary Chapter 11
8. Verenium Announces First Commercial Cellulosic Ethanol Project
9. ETS Laboratories Offers New Process Optimization Tools to the Fuel Ethanol Industry
10. POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol
11. Dartmouth researchers advance cellulosic ethanol production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook Labs ... to include an array of biochemical analyses critical for Lead Discovery. The ... hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of action, and ...
(Date:2/23/2017)... 2017  Imanis Life Sciences announced today the ... vaccinia viruses for virotherapy research. These viruses are ... proprietary, vaccinia virus-based technology platform for research use. ... a partnership with Genelux to offer researchers, for ... use in research," said Dr. Kah Whye ...
(Date:2/23/2017)... NC (PRWEB) , ... February 23, 2017 , ... ... to announce a new partnership with Compass Research . GGI's mission is to ... a vaccine to a child in need in honor of each clinical trial volunteer. ...
(Date:2/22/2017)... Kan. , Feb. 22, 2017  Aratana Therapeutics, Inc. ... development and commercialization of innovative biopharmaceutical products for companion animals, ... 2017 at 8:30 a.m. ET to discuss financial results from ... Interested participants and investors may access the ... ...
Breaking Biology Technology:
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
(Date:2/8/2017)... Report Highlights The global biosurgery ... billion in 2016 at a compound annual growth rate ... Includes - An overview of the global market for ... from 2015 and 2016, and projections of compound annual ... market on the basis of product type, source, application, ...
(Date:2/7/2017)... LONG BEACH, New York , February 7, 2017 ... formerly known as ID Global Solutions Corporation [OTC: IDGS], ... identification, identity management and electronic transaction processing services, is ... a reorganization of the Company. Effective January ... Chairman of the Board of Directors, CEO and President. ...
Breaking Biology News(10 mins):